Inflammation, infection and acute coronary plaque events

European Heart Journal, Supplement

Volumn 3, Issue I, 2001, Pages

  Kaski, Juan Carlos ^a   Zouridakis, E G ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acute coronary syndromes; Anti inflammatory; Anti platelet; Atherosclerosis; Unstable atheromatous plaques

Indexed keywords

2 HYDROXY 4 (TRIFLUOROMETHYL)BENZOIC ACID; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTITHROMBOCYTIC AGENT; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CERIVASTATIN; COLONY STIMULATING FACTOR 1; CYTOKINE; DRUG METABOLITE; HYPOCHOLESTEROLEMIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PRAVASTATIN; TRIFLUSAL; UNCLASSIFIED DRUG;

ACUTE DISEASE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY THROMBOSIS; CYTOKINE PRODUCTION; DRUG MECHANISM; FIBROSIS; HEART MUSCLE ISCHEMIA; HIGH RISK PATIENT; HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE ACTIVATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVIEW; WINE;

EID: 0034898339     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(01)90101-4     Document Type: Review

References (49)

1. Phloge and thrombose im gefaessystem
2. Atherosclerosis - An inflammatory disease
3. The pathogenesis of atherosclerosis: A perspective for the 1990s
4. The pathophysiology of acute coronary syndromes
5. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death
6. Reactive oxygen species, metalloproteinases, and plaque stability
7. Molecular bases of the acute coronary syndromes
8. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture
9. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction
10. Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases
11. Nuclear factor-kappaB is selectively and markedly activated in humans with unstable angina pectoris
12. Expression of interleukin-10 in advanced human atherosclerotic plaques: Relation to inducible nitric oxide synthase expression and cell death
13. Interleukin-10
14. IL-10: An 'immunologic scalpel' for atherosclerosis?
15. Protective role of interleukin-10 in atherosclerosis
16. Interleukin-10 blocks atherosclerotic events in vitro and in vivo
17. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes
18. Acute T-cell activation is detectable in unstable angina
19. Increasing levels of interleukin (IL)-IRa and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events
20. C-reactive protein in patients with chronic stable angina: Differences in baseline serum concentration between women and men
21. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina
22. Independent prognostic value of elevated C-reactive protein in unstable angina
23. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
24. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
25. Serum neopterin in acute coronary syndromes
26. Increased neopterin in patients with chronic and acute coronary syndromes
27. Serum neopterin and complex stenosis morphology in patients with unstable angina
28. Increased serum neopterin: A marker of coronary artery disease activity in women
29. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes
30. Chronic infections and coronary heart disease: Is there a link?
31. Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: A potential link to accelerated arteriosclerosis
32. Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice
33. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs
34. The aspirin and heme-binding sites of ovine and murine prostaglandin endoperoxide synthases
35. Inhibition of tumor necrosis factor-induced p42/p44 mitogen-activated protein kinase activation by sodium salicylate
36. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin
37. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
38. Inflammation, aspirin, and the risk of cardiovascular disease
39. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
40. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study
41. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis
42. Pravastatin has cholesterol-lowering independent effects on the artery wall of atherosclerotic monkeys
43. An HMG-CoA reductase inhibitor (Cerivastatin) suppresses accumulation of macrophages expressing matrix metalloproteinases and tissue factor in atheroma of WHHL rabbits
44. Long-term effects of pravastatin on plasma concentration of C-reactive protein
45. Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia
46. The effects of light to moderate drinking on cardiovascular diseases
47. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction
48. May aspirin be replaced in the treatment of myocardial infarction?
49. 4-Trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation